Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
1282
-
Total 13F shares, excl. options
-
71.9M
-
Shares change
-
-2.4M
-
Total reported value, excl. options
-
$45.9B
-
Value change
-
-$1.43B
-
Put/Call ratio
-
0.79
-
Number of buys
-
556
-
Number of sells
-
-565
-
Price
-
$638.89
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q3 2025
1,396 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q3 2025.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 1,282 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.9M shares
of 80.8M outstanding shares and own 88.99% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.96M shares), BlackRock, Inc. (8.21M shares), STATE STREET CORP (3.52M shares), Fundsmith LLP (2.61M shares), GEODE CAPITAL MANAGEMENT, LLC (2.5M shares), Bank of New York Mellon Corp (2.06M shares), BAMCO INC /NY/ (1.88M shares), MORGAN STANLEY (1.62M shares), Invesco Ltd. (1.32M shares), and PRINCIPAL FINANCIAL GROUP INC (1.32M shares).
This table shows the top 1282 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.